The new landscape of medication adherence improvement: where population health science meets precision medicine.
| dc.contributor.author | Zullig, Leah L | |
| dc.contributor.author | Blalock, Dan V | |
| dc.contributor.author | Dougherty, Samantha | |
| dc.contributor.author | Henderson, Rochelle | |
| dc.contributor.author | Ha, Carolyn C | |
| dc.contributor.author | Oakes, Megan M | |
| dc.contributor.author | Bosworth, Hayden B | |
| dc.date.accessioned | 2024-01-26T16:18:11Z | |
| dc.date.available | 2024-01-26T16:18:11Z | |
| dc.date.issued | 2018-01 | |
| dc.description.abstract | Despite the known health and economic benefits of medications, nonadherence remains a significant, yet entirely preventable public health burden. Over decades, there have been numerous research studies evaluating health interventions and policy efforts aimed at improving adherence, yet no universal or consistently high impact solutions have been identified. At present, new challenges and opportunities in policy and the movement toward value-based care should foster an environment that appreciates adherence as a mechanism to improve health outcomes and control costs (eg, fewer hospitalizations, reduced health care utilization). Our objective was to provide a commentary on recent changes in the landscape of research and health policy directed toward improving adherence and an actionable agenda to achieve system level savings and improved health by harnessing the benefits of medications. Specifically, we address the complementary perspectives of precision medicine and population health management; integrating data sources to develop innovative measurement of adherence and target adherence interventions; and behavioral economics to determine appropriate incentives. | |
| dc.identifier | ppa-12-1225 | |
| dc.identifier.issn | 1177-889X | |
| dc.identifier.issn | 1177-889X | |
| dc.identifier.uri | ||
| dc.language | eng | |
| dc.publisher | Informa UK Limited | |
| dc.relation.ispartof | Patient preference and adherence | |
| dc.relation.isversionof | 10.2147/ppa.s165404 | |
| dc.rights.uri | ||
| dc.subject | adherence | |
| dc.subject | policy | |
| dc.subject | population health | |
| dc.subject | precision medicine | |
| dc.title | The new landscape of medication adherence improvement: where population health science meets precision medicine. | |
| dc.type | Journal article | |
| duke.contributor.orcid | Zullig, Leah L|0000-0002-6638-409X | |
| duke.contributor.orcid | Blalock, Dan V|0000-0002-8349-9825 | |
| duke.contributor.orcid | Bosworth, Hayden B|0000-0001-6188-9825 | |
| pubs.begin-page | 1225 | |
| pubs.end-page | 1230 | |
| pubs.organisational-group | Duke | |
| pubs.organisational-group | School of Medicine | |
| pubs.organisational-group | Basic Science Departments | |
| pubs.organisational-group | Clinical Science Departments | |
| pubs.organisational-group | Institutes and Centers | |
| pubs.organisational-group | Medicine | |
| pubs.organisational-group | Psychiatry & Behavioral Sciences | |
| pubs.organisational-group | Medicine, General Internal Medicine | |
| pubs.organisational-group | Duke Cancer Institute | |
| pubs.organisational-group | Duke Clinical Research Institute | |
| pubs.organisational-group | Institutes and Provost's Academic Units | |
| pubs.organisational-group | Center for the Study of Aging and Human Development | |
| pubs.organisational-group | Initiatives | |
| pubs.organisational-group | Duke Science & Society | |
| pubs.organisational-group | Population Health Sciences | |
| pubs.organisational-group | Duke Innovation & Entrepreneurship | |
| pubs.organisational-group | Psychiatry & Behavioral Sciences, Behavioral Medicine & Neurosciences | |
| pubs.organisational-group | Duke - Margolis Center For Health Policy | |
| pubs.publication-status | Published | |
| pubs.volume | 12 |
Files
Original bundle
- Name:
- The new landscape of medication adherence improvement where population health science meets precision medicine.pdf
- Size:
- 287.84 KB
- Format:
- Adobe Portable Document Format